Related content

Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

By Mitchell Cathrine   Gregersen Nerine   Krause Amanda  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 953-963

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic Screening of the Gene Deletion and Duplications of CYP2D6

By Meijerman Irma   Sanderson Linda   Smits Paul   Beijnen Jos   Schellens Jan  

Drug Metabolism Reviews, Vol. 39, Iss. 1, 2007-01 ,pp. : 45-60

Informa Healthcare

Access to resources Recommend Favorite

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity

By Dandara Collet   Lombard Zané   Du Plooy Ingrid   McLellan Tracy   Norris Shane A   Ramsay Michèle  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1663-1670

Future Medicine

Access to resources Recommend Favorite

Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants

By Montané Jaime Lazara Karelia   Lalla Anthony   Steimer Werner   Gaedigk Andrea  

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 261-276

Future Medicine

Access to resources Recommend Favorite

Variants of the CYP11B2 gene predict response to therapy with candesartan

By Ortlepp J.R.   Hanrath P.   Mevissen V.   Kiel G.   Borggrefe M.   Hoffmann R.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 151-152

Elsevier

Access to resources Recommend Favorite